Bath & Body Works, Inc. (NYSE:BBWI) Stock Has Consensus Price Target of $22.53 According to Brokerages

Bath & Body Works logo with Consumer Discretionary background
Image from MarketBeat Media, LLC.

Key Points

  • Analysts have a consensus “Hold” rating on Bath & Body Works, with 15 holds, four buys and one sell among 20 firms. Their average 12-month price target is $22.53.
  • The stock opened at $18.68, below its 50-day and 200-day moving averages. Recent targets varied, including Wells Fargo’s $25 and UBS’s $22.
  • Latest reported quarterly earnings beat estimates at $0.62 per share, though revenue declined 2.3% year over year. The company announced a quarterly dividend of $0.20 per share, equivalent to a 4.3% yield.
  • Five stocks to consider instead of Bath & Body Works.

Shares of Bath & Body Works, Inc. (NYSE:BBWI - Get Free Report) have been given an average rating of "Hold" by the twenty research firms that are covering the company, Marketbeat Ratings reports. One equities research analyst has rated the stock with a sell rating, fifteen have given a hold rating and four have given a buy rating to the company. The average 1-year price target among brokerages that have issued ratings on the stock in the last year is $22.53.

Several analysts have recently weighed in on the company. UBS Group boosted their target price on Bath & Body Works from $17.00 to $22.00 and gave the company a "neutral" rating in a report on Friday, November 13th. Deutsche Bank set a $22.00 target price on Bath & Body Works in a research report on Thursday, August 27th. Weiss Ratings restated a "hold (c-)" rating on shares of Bath & Body Works in a research note on Tuesday, October 6th. BMO Capital Markets assumed coverage on Bath & Body Works in a research report on Tuesday, September 8th. They set a "market perform" rating and a $20.00 price target on the stock. Finally, Wells Fargo & Company lifted their price target on Bath & Body Works from $24.00 to $25.00 and gave the stock an "overweight" rating in a research report on Thursday, October 29th.

View Our Latest Analysis on BBWI

Hedge Funds Weigh In On Bath & Body Works

Institutional investors have recently modified their holdings of the business. BlackRock Inc. acquired a new stake in Bath & Body Works during the 2nd quarter worth $449,065,000. Bank of America Corp DE acquired a new position in Bath & Body Works in the second quarter valued at $62,249,000. Bank of New York Mellon Corp acquired a new position in Bath & Body Works in the second quarter valued at $59,260,000. Marshall Wace LLP increased its stake in Bath & Body Works by 458.9% in the third quarter. Marshall Wace LLP now owns 3,260,323 shares of the company's stock valued at $51,904,000 after purchasing an additional 2,677,026 shares during the period. Finally, Arrowstreet Capital Limited Partnership raised its holdings in shares of Bath & Body Works by 34.2% in the first quarter. Arrowstreet Capital Limited Partnership now owns 2,777,576 shares of the company's stock valued at $51,857,000 after buying an additional 707,449 shares during the last quarter. 95.14% of the stock is owned by institutional investors and hedge funds.

Bath & Body Works Trading Up 1.5%

Shares of Bath & Body Works stock opened at $18.68 on Thursday. The company has a fifty day simple moving average of $19.21 and a 200-day simple moving average of $19.78. Bath & Body Works has a 12-month low of $14.27 and a 12-month high of $24.94. The stock has a market cap of $3.77 billion, a price-to-earnings ratio of 4.86, a PEG ratio of 0.92 and a beta of 1.31.

Bath & Body Works (NYSE:BBWI - Get Free Report) last announced its quarterly earnings results on Wednesday, August 26th. The company reported $0.62 EPS for the quarter, topping the consensus estimate of $0.24 by $0.38. Bath & Body Works had a net margin of 10.83% and a negative return on equity of 53.48%. The firm had revenue of $1.51 billion for the quarter, compared to analyst estimates of $1.50 billion. During the same period last year, the business earned $0.30 EPS. Bath & Body Works's revenue for the quarter was down 2.3% compared to the same quarter last year. Bath & Body Works has set its Q3 2026 guidance at 0.070-0.120 EPS and its FY 2026 guidance at 2.600-2.800 EPS. On average, analysts forecast that Bath & Body Works will post 2.74 earnings per share for the current fiscal year.

Bath & Body Works Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, December 4th. Stockholders of record on Friday, November 20th will be given a dividend of $0.20 per share. The ex-dividend date is Friday, November 20th. This represents a $0.80 dividend on an annualized basis and a dividend yield of 4.3%. Bath & Body Works's dividend payout ratio (DPR) is 20.83%.

About Bath & Body Works

(Get Free Report)

Bath & Body Works, Inc. is a specialty retailer focused on personal care and home fragrance products. Its offerings include body lotions, soaps, fragrances, hand sanitizers, candles and other home-fragrance items, sold under the Bath & Body Works and White Barn brands. The company serves customers through its stores and e-commerce platform in the United States and Canada, as well as through international franchise, license and wholesale partners. Bath & Body Works traces its roots to a store launched in 1990.

Further Reading

Analyst Recommendations for Bath & Body Works (NYSE:BBWI)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Bath & Body Works Right Now?

Before you consider Bath & Body Works, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Bath & Body Works wasn't on the list.

While Bath & Body Works currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Blue-Chip Stocks to Add To Your Forever Portfolio Cover

A strong long-term portfolio starts with companies that can survive recessions, inflation, changing consumer habits, and shifting market leadership.

This report names seven blue-chip stocks across technology, retail, consumer staples, healthcare, networking, sporting goods, and utilities that offer investors a mix of stability, income, growth, and staying power.

Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines